Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IST/RTALB stock hub

IST/RTALB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/RTALBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/RTALB

In the news

Latest news · IST/RTALB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E2.3

P25 n/aP50 n/aP75 n/a

ROE34.2

P25 n/aP50 n/aP75 n/a

ROIC-0.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/RTALB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

TRY

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	81
Employees Change	14%
Employees Change Percent	20.9
Enterprise value	TRY 2.1B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Biotechnology
Isin	TRERTAL00018
Last refreshed	2026-05-10
Market cap	TRY 2B
Price	TRY 4
Price currency	TRY
Rev Per Employee	2,957,571x
Sector	Healthcare
Sic	2836
Symbol	ist/RTALB
Website	https://www.rtalabs.com.tr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	44.06%
EV Earnings	2.39x
EV/EBIT	1.94x
EV/EBITDA	1.89x
EV/FCF	17.43x
EV/Sales	8.8x
FCF yield	6.05%
P/B ratio	0.67x
P/E ratio	2.27x
P/S ratio	8.35x
PE Ratio10 Y	14.09x
PE Ratio5 Y	8.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.43%
EBITDA Margin	3.83%
FCF margin	50.49%
Gross margin	33.94%
Gross Profit	TRY 81.3M
Gross Profit Growth	51.56%
Gross Profit Growth Q	60.85%
Gross Profit Growth3 Y	7.98%
Gross Profit Growth5 Y	-1.18%
Net Income	TRY 881.2M
Net Income Growth	1,188.82%
Net Income Growth Q	1,331.05%
Net Income Growth5 Y	70.62%
Pretax Margin	521.51%
Profit Margin	367.83%
Profit Per Employee	TRY 10.9M
ROA	-0.37
Roa5y	1.93
ROCE	-0.54
ROE	34.22
Roe5y	19.72
ROIC	-0.46
Roic5y	6.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	33.93%
Cagr1y	31.6%
Cagr3y	39.85%
Cagr5y	14.75%
EPS Growth	1,189.2
EPS Growth Q	1,329.9
EPS Growth5 Y	69.03
OCF Growth Q	-94.98%
OCF Growth10 Y	37.95%
OCF Growth3 Y	62.41%
OCF Growth5 Y	75.13%
Revenue Growth	15.41x
Revenue Growth Q	42.28x
Revenue Growth3 Y	7.79x
Revenue Growth5 Y	0.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 0.08
Assets	TRY 3.4B
Cash	TRY 10.5M
Current Assets	TRY 185.3M
Current Liabilities	TRY 134.2M
Debt	TRY 119.1M
Debt EBITDA	TRY 8.57
Debt Equity	TRY 0.04
Debt FCF	TRY 0.98
Equity	TRY 3B
Interest Coverage	-0.25
Liabilities	TRY 468.9M
Long Term Assets	TRY 3.2B
Long Term Liabilities	TRY 334.7M
Net Cash	TRY -108.7M
Net Cash By Market Cap	TRY -5.43
Net Debt EBITDA	TRY 11.85
Net Debt Equity	TRY 0.04
Net Debt FCF	TRY 0.9
Tangible Book Value	TRY 3B
Tangible Book Value Per Share	TRY 5.93
WACC	8.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Inventory Turnover	3.31
Net Working Capital	TRY 143.1M
Quick ratio	0.86
Working Capital	TRY 51.1M
Working Capital Turnover	TRY -17.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,756.28%
1Y total return	31.58%
200-day SMA	3.75
3Y total return	173.6%
50-day SMA	3.68
50-day SMA vs 200-day SMA	50under200
5Y total return	98.91%
All Time High	6.51
All Time High Change	-38.57%
All Time High Date	2024-09-03
All Time Low	0.1
All Time Low Change	3,981.63%
All Time Low Date	2019-08-22
ATR	0.15
Beta	0.34
Beta1y	0.96
Beta2y	0.38
Ch YTD	16.62
High	4
High52	4.8
High52 Date	2025-10-06
High52ch	-16.67%
Low	3.83
Low52	2.59
Low52 Date	2025-06-23
Low52ch	54.44%
Ma50ch	8.64%
Price vs 200-day SMA	6.55%
RSI	64.01
RSI Monthly	56.67
RSI Weekly	57.36
Sharpe ratio	0.73x
Sortino ratio	1.3
Total Return	0.03%
Tr YTD	16.62
Tr1m	15.61%
Tr1w	23.46%
Tr3m	-1.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY -17.8M
Operating margin	-7.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	350,002,735%
Net Borrowing	-176,359,085
Shares Institutions	2.76%
Shares Out	500,000,000
Shares Qo Q	0%
Shares Yo Y	-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 121M
Average Volume	39,564,569.55x
Bv Per Share	5.93
CAPEX	TRY -33.4M
Ch10y	1,631.6
Ch1m	15.61
Ch1w	23.46
Ch1y	31.58
Ch3m	-1.23
Ch3y	173.6
Ch5y	98.91
Ch6m	-0.25
Change	9.89%
Change From Open	4.17
Close	3.64
Days Gap	5.49
Depreciation Amortization	26,973,728
Dollar Volume	234,744,720
Earnings Date	2026-05-11
EBIT	TRY -17.8M
EBITDA	TRY 9.2M
EPS	TRY 1.76
F Score	5
FCF	TRY 121M
FCF EV Yield	5.74x
FCF Per Share	TRY 0.24
Financing CF	-236,739,576
Fiscal Year End	December
Founded	1,996
Graham Number	15.33437
Graham Upside	283.4
Income Tax	TRY 368.2M
Investing CF	80,542,784
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2025-12-31
Last Split Date	2025-03-19
Last Split Type	Forward
Lynch Fair Value	TRY 44.06
Lynch Upside	1,001.5
Ma150	3.79
Ma150ch	5.49%
Ma20	3.59
Ma20ch	11.42%
Net CF	-3,820,389
Next Earnings Date	2026-05-11
Open	3.84
P FCF Ratio	16.53
P OCF Ratio	12.95
Position In Range	100
Ppne	388,792,416
Price Date	2026-05-08
Price EBITDA	TRY 218
Ptbv Ratio	0.67
Relative Volume	1.48x
Revenue	239,563,251x
Tax By Revenue	153.68x
Tax Rate	29.47%
Tr6m	-0.25%
Volume	58,686,180
Z Score	3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/RTALB pay a dividend?

Capital-return profile for this ticker.

Performance

IST/RTALB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/RTALB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

IST/RTALB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.0

Neutral momentum band

Price vs 200-day MA

+6.6%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/RTALB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/RTALB stock rating?

ist/RTALB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/RTALB analysis?

The full report lives at /stocks/ist/RTALB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/RTALB?

The latest report frames ist/RTALB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/RTALB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.